Literature DB >> 9379067

The safety and utilization of patient-controlled analgesia.

D Sidebotham1, M R Dijkhuizen, S A Schug.   

Abstract

Between December 1989 and March 1996, more than 6000 patients were treated with patient-controlled analgesia (PCA) at Auckland Hospital. The overall incidence of potentially life-threatening complications was low (0.28%). A small number (276) received PCA with a background opioid infusion. This technique was associated with a higher incidence of such complications (1.08%, P < 0.05). To further characterize the safety and utilization of PCA, a subgroup of 300 patients was analyzed. The average duration of PCA was 76.4 +/- 39.2 hr. The peak morphine consumption was highest on the day of operation (45.4 +/- 37.0 mg) and rapidly declined over the next 3 postoperative days (40.6 +/- 39.0, 33.3 +/- 26.2, and 27.8 +/- 36.6 mg, respectively). The ratio of drug demands to deliveries decreased from 1.76 on the morning of the first postoperative day to 1.17 on the evening of the third. The percentage of patients with inadequate analgesia (pain score > or = 3/10) and an inability to comply with physiotherapy (Bruggemann comfort score < or = 2/10) was high on the first postoperative day (42% and 18%, respectively). Men used significantly more morphine than women (141.7 +/- 123.6 versus 102.7 +/- 111.2 mg, P < 0.0001) and general surgical patients used more morphine than urology and orthopedic patients (152.6 +/- 136.9 versus 96.0 +/- 84.2 and 83.7 +/- 97.9 mg, P < 0.0001). There was no association between morphine consumption and age (r = -0.216). Of the 6% of patients who experienced hypoxemia and 2% who experienced respiratory depression, virtually all had one of three risk factors: bolus dose greater than 1 mg morphine, age greater than 65 years, or intra-abdominal surgery. The most common side effects were nausea and sedation. The incidence of nausea was highest on day 1 (28%) and decreased over the next 2 days (14.3% and 4.7%, respectively). A similar pattern was observed with sedation (incidence over the first 3 days: 28%, 9.3%, and 3.3%, respectively). Overall patient satisfaction scores were high (8.3/10 +/- 1.9). We conclude that the risk of serious complications with PCA is very low, but worrying degrees of hypoxemia and bradypnea do occur. We suggest prescribing regimens that may reduce complications and identify patients at high risk.

Entities:  

Mesh:

Year:  1997        PMID: 9379067     DOI: 10.1016/s0885-3924(97)00182-6

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  18 in total

1.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

2.  Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain.

Authors:  A Ruggiero; G Barone; L Liotti; A Chiaretti; I Lazzareschi; R Riccardi
Journal:  Support Care Cancer       Date:  2006-12-05       Impact factor: 3.603

3.  Finding the 'ideal' regimen for fentanyl-based intravenous patient-controlled analgesia: how to give and what to mix?

Authors:  Seokyung Shin; Keoung Tae Min; Yang Sik Shin; Hyung Min Joo; Young Chul Yoo
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

4.  A risk stratification algorithm using non-invasive respiratory volume monitoring to improve safety when using post-operative opioids in the PACU.

Authors:  Christopher Voscopoulos; Kimberly Theos; H A Tillmann Hein; Edward George
Journal:  J Clin Monit Comput       Date:  2016-02-19       Impact factor: 2.502

5.  Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study.

Authors:  Michael Grach; Wattan Massalha; Dorit Pud; Rivka Adler; Elon Eisenberg
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

Review 6.  Patient-controlled analgesia-related medication errors in the postoperative period: causes and prevention.

Authors:  Jeff R Schein; Rodney W Hicks; Winnie W Nelson; Vanja Sikirica; D John Doyle
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  External Validation of a Recently Developed Population Pharmacokinetic Model for Hydromorphone During Postoperative Pain Therapy.

Authors:  Harald Ihmsen; Doris Rohde; Jürgen Schüttler; Christian Jeleazcov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

8.  Abuse liability of oxycodone as a function of pain and drug use history.

Authors:  S D Comer; M A Sullivan; S K Vosburg; W J Kowalczyk; J Houser
Journal:  Drug Alcohol Depend       Date:  2010-01-15       Impact factor: 4.492

9.  Patient-controlled analgesia with fentanil and midazolam in children with postoperative neurosurgical pain.

Authors:  Antonio Chiaretti; Orazio Genovese; Alessia Antonelli; Luca Tortorolo; Antonio Ruggiero; Benedetta Focarelli; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2007-07-17       Impact factor: 1.475

10.  Patient perspectives of patient-controlled analgesia (PCA) and methods for improving pain control and patient satisfaction.

Authors:  Lance S Patak; Alan R Tait; Leela Mirafzali; Michelle Morris; Sunavo Dasgupta; Chad M Brummett
Journal:  Reg Anesth Pain Med       Date:  2013 Jul-Aug       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.